Knowledge of a treatment assignment can influence expectations, reporting, or assessment. Blinding aims to limit that influence, but the label is more useful when the paper explains whose knowledge was restricted.
The National Cancer Institute’s double-blind definition describes a trial in which participants and researchers do not know the assigned treatment during the blinded study period.
Name the roles in your notes
Look for participants, people delivering an intervention, outcome assessors, and analysts. A methods section may describe these roles more precisely than a short headline using “double-blind.”
In an invented exercise comparing two information formats, the person handing out the material may recognise the format, while someone scoring an anonymised response may not know which version produced it. That is a specific arrangement, not an all-or-nothing description of everyone’s knowledge.
Some interventions are difficult to conceal. The useful response is to examine how the researchers handled that limitation rather than assuming the entire study has no value.
Also distinguish blinding from random assignment. One concerns knowledge of allocation; the other concerns how allocation is made. Recording both separately produces a clearer account of the methods and prevents one reassuring label from standing in for the whole study design.
Editorial illustration from this site’s image library; not documentary evidence of the example or object discussed.

